Search results
University president dies after 3 year battle with sarcoma: What to know about rare cancer
USA Today· 4 days ago"The days ahead will be full of heartbreak," the university's statement said. On Sunday, the...
Marquette University President Michael Lovell dies while abroad
TMJ4 Milwaukee· 4 days agoMichael Lovell, President of Marquette University, died while on a trip to Italy, the university...
Marquette University President Michael Lovell, who had ties to Pitt, dies at 57
Pittsburgh Tribune-Review· 13 hours agoMichael Lovell, the president of Marquette University with deep ties to the University of...
FAP-targeted therapy demonstrates significant efficacy in controlling advanced sarcomas
Medical Xpress· 3 days agoFibroblast activation protein (FAP)-targeted radioligand therapy is safe and effective for treating patients with progressive metastatic tumors, specifically advanced sarcomas
Michael Lovell, Marquette University president, dies at 57
CBS News· 3 days agoLovell had been battling sarcoma, a rare form of cancer, for three years.
27-year-old battling rare cancer uses social media to help break stigmas
ABC7 News· 2 days agoComplementing the 27 year old's glasses in her daily outfits is an accessory most don't have: a...
Marquette president Michael Lovell dies from cancer in Rome
New York Daily News· 3 days agoMarquette University president Michael Lovell died from cancer Sunday while on a trip in Rome, the...
Marquette University president loses battle with cancer while overseas
WBAY Green Bay· 4 days agoThe president of Marquette University, Michael Lovell, passed away on Sunday while on a trip to...
Marquette University president dies
WISN 12 Milwaukee· 4 days agoMarquette University President Dr. Michael Lovell died Sunday in Rome. Lovell was diagnosed with sarcoma, a rare form of cancer in 2021. In a statement...
President of Marquette University dies while on trip to Italy
NBC Chicago· 4 days agoPresident Michael Lovell and his wife, Amy, were in Rome with members of the Society of Jesus and...